Annalaura Montella
Overview
Explore the profile of Annalaura Montella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cardinale A, Cantalupo S, Lasorsa V, Montella A, Cimmino F, Succoio M, et al.
Hum Mol Genet
. 2021 Oct;
31(6):863-874.
PMID: 34605909
The 10q24.33 locus is known to be associated with susceptibility to cutaneous malignant melanoma (CMM), but the mechanisms underlying this association have been not extensively investigated. We carried out an...
12.
Capasso M, Montella A, Tirelli M, Maiorino T, Cantalupo S, Iolascon A
Front Oncol
. 2020 Nov;
10:590033.
PMID: 33194750
Progresses over the past years have extensively improved our capacity to use genome-scale analyses-including high-density genotyping and exome and genome sequencing-to identify the genetic basis of pediatric tumors. In particular,...
13.
Avitabile M, Lasorsa V, Cantalupo S, Cardinale A, Cimmino F, Montella A, et al.
J Cell Mol Med
. 2020 Feb;
24(7):4072-4081.
PMID: 32103589
The genetic aetiology and the molecular mechanisms that characterize high-risk neuroblastoma are still little understood. The majority of high-risk neuroblastoma patients do not take advantage of current induction therapy. So...
14.
Cimmino F, Avitabile M, Lasorsa V, Pezone L, Cardinale A, Montella A, et al.
J Cancer
. 2020 Feb;
11(6):1495-1504.
PMID: 32047556
is associated with the development of high-risk neuroblastoma patients. Particularly, the expression of full length (FL) isoform, FL , correlates to high-risk neuroblastoma development and its inhibition is sufficient to...
15.
Capasso M, Lasorsa V, Cimmino F, Avitabile M, Cantalupo S, Montella A, et al.
Cancer Res
. 2019 Dec;
80(3):382-393.
PMID: 31784426
The contribution of coding mutations to oncogenesis has been largely clarified, whereas little is known about somatic mutations in noncoding DNA and their role in driving tumors remains controversial. Here,...
16.
Avitabile M, Succoio M, Testori A, Cardinale A, Vaksman Z, Lasorsa V, et al.
Carcinogenesis
. 2019 Oct;
41(3):284-295.
PMID: 31605138
Neuroblastoma (NB) and malignant cutaneous melanoma (CMM) are neural crest cells (NCC)-derived tumors and may have a shared genetic basis, but this has not been investigated systematically by genome-wide association...
17.
Cimmino F, Avitabile M, Lasorsa V, Montella A, Pezone L, Cantalupo S, et al.
BMC Med Genet
. 2019 Feb;
20(1):37.
PMID: 30808328
Background: HIF1A (Hypoxia-Inducible-Factor 1A) expression in solid tumors is relevant to establish resistance to therapeutic approaches. The use of compounds direct against hypoxia signaling and HIF1A does not show clinical...